Atrial proteomic profiling reveals a switch towards profibrotic gene expression program in CREM-IbΔC-X mice with persistent atrial fibrillation

被引:1
|
作者
Zhao, Shuai [1 ,2 ]
Hulsurkar, Mohit M. [1 ,2 ]
Lahiri, Satadru K. [1 ,2 ]
Aguilar-Sanchez, Yuriana [1 ,2 ]
Munivez, Elda [1 ,2 ]
Mueller, Frank Ulrich [3 ]
Jain, Antrix [4 ]
Malovannaya, Anna [4 ,5 ]
Yiu, Chi Him Kendrick [6 ]
Reilly, Svetlana [6 ]
Wehrens, Xander H. T. [1 ,2 ,7 ,8 ,9 ,10 ]
机构
[1] Baylor Coll Med, Cardiovasc Res Inst, One Baylor Plaza,BCM335, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Integrat Physiol, Houston, TX 77030 USA
[3] Univ Munster, Inst Pharmacol & Toxicol, Munster, Germany
[4] Baylor Coll Med, Mass Spectrometry Prote Core, Houston, TX USA
[5] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA
[6] Univ Oxford, John Radcliffe Hosp, British Heart Fdn Ctr Res Excellence, Radcliffe Dept Med,Div Cardiovasc Med,NIHR Oxford, Oxford, England
[7] Baylor Coll Med, Dept Med Cardiol, Houston, TX 77030 USA
[8] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA
[9] Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA
[10] Baylor Coll Med, Ctr Space Med, Houston, TX USA
关键词
Atrial fibrillation; Atrial fibrosis; Extracellular matrix; Disease model; Proteomics; EXTRACELLULAR-MATRIX; FIBROSIS; PROTEOSTASIS; MECHANISMS; MANAGEMENT; MODELS;
D O I
10.1016/j.yjmcc.2024.03.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Overexpression of the CREM (cAMP response element-binding modulator) isoform CREM-Ib Delta C-X in transgenic mice (CREM-Tg) causes the age-dependent development of spontaneous AF. Purpose: To identify key proteome signatures and biological processes accompanying the development of persistent AF through integrated proteomics and bioinformatics analysis. Methods: Atrial tissue samples from three CREM-Tg mice and three wild-type littermates were subjected to unbiased mass spectrometry-based quantitative proteomics, differential expression and pathway enrichment analysis, and protein-protein interaction (PPI) network analysis. Results: A total of 98 differentially expressed proteins were identified. Gene ontology analysis revealed enrichment for biological processes regulating actin cytoskeleton organization and extracellular matrix (ECM) dynamics. Changes in ITGAV, FBLN5, and LCP1 were identified as being relevant to atrial fibrosis and structural based on expression changes, co-expression patterns, and PPI network analysis. Comparative analysis with previously published datasets revealed a shift in protein expression patterns from ion-channel and metabolic regulators in young CREM-Tg mice to profibrotic remodeling factors in older CREM-Tg mice. Furthermore, older CREM-Tg mice exhibited protein expression patterns reminiscent of those seen in humans with persistent AF. Conclusions: This study uncovered distinct temporal changes in atrial protein expression patterns with age in CREM-Tg mice consistent with the progressive evolution of AF. Future studies into the role of the key differentially abundant proteins identified in this study in AF progression may open new therapeutic avenues to control atrial fibrosis and substrate development in AF.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 14 条
  • [1] Characterization of the Genetic Program Linked to the Development of Atrial Fibrillation in CREM-IbΔC-X Mice
    Seidl, Matthias D.
    Stein, Juliane
    Hamer, Sabine
    Pluteanu, Florentina
    Scholz, Beatrix
    Wardelmann, Eva
    Huge, Andreas
    Witten, Anika
    Stoll, Monika
    Hammer, Elke
    Voelker, Uwe
    Mueller, Frank U.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (08):
  • [2] Atrial phenotype of homozygous CREM-IbΔC-X transgenic mice
    Stein, J.
    Himmler, K.
    Scholz, B.
    Schmitz, W.
    Mueller, F. U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S80 - S80
  • [3] Ionic currents altered by atrial fibrillation onset in atrial myocytes of CREM-IbΔC-X transgenic mice
    Pluteanu, F.
    Seidl, M.
    Scholz, B.
    Hamer, S.
    Mueller, F. U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S41 - S42
  • [4] Homozygous CREM-IbΔC-X Overexpressing Mice Are a Reliable and Effective Disease Model for Atrial Fibrillation
    Stuempel, Frank T.
    Stein, Juliane
    Himmler, Kirsten
    Scholz, Beatrix
    Seidl, Matthias D.
    Skryabin, Boris, V
    Mueller, Frank U.
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [5] Valproic acid reduces atrial enlargement in CREM-IbΔC-X transgenic mice
    Scholz, B.
    Stein, J.
    Himmler, K.
    Schmitz, W.
    Mueller, F. U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S73 - S73
  • [6] Valproic acid attenuates structural atrial remodeling in CREM-IbΔC-X transgenic mice
    Scholz, B.
    Stein, J.
    Himmler, K.
    Seidl, M. D.
    Schulte, J. S.
    Hamer, S.
    Wardelmann, E.
    Hammer, E.
    Voelker, U.
    Mueller, F. U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S38 - S38
  • [7] Inactivation of HDAC2 attenuates atrial structural and functional remodeling in CREM-IbΔC-X transgenic mice, a mouse model of spontaneous onset atrial fibrillation
    Schulte, J. S.
    Reinhardt, J. P.
    Hamer, S.
    Scholz, B.
    Seidl, M. D.
    Mueller, F. U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2020, 393 (SUPPL 1) : 19 - 19
  • [8] Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes
    Schulte, J. S.
    Fehrmann, E.
    Tekook, M. A.
    Kranick, D.
    Fels, B.
    Li, N.
    Wehrens, X. H. T.
    Heinick, A.
    Seidl, M. D.
    Schmitz, W.
    Mueller, F. U.
    BASIC RESEARCH IN CARDIOLOGY, 2016, 111 (02) : 1 - 12
  • [9] The transcription factor isoform CREM-Ib?C-X is an important regulator of the normal structural and function organization of the atrial myocardium in mice
    Marijon, E.
    Schulte, K.
    Schulte, J. S.
    Moubarak, G.
    Muller, F.
    Hatem, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 48 - 48
  • [10] Cardiac expression of the CREM repressor isoform CREM-IbΔC-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes
    J. S. Schulte
    E. Fehrmann
    M. A. Tekook
    D. Kranick
    B. Fels
    N. Li
    X. H. T. Wehrens
    A. Heinick
    M. D. Seidl
    W. Schmitz
    F. U. Müller
    Basic Research in Cardiology, 2016, 111